Search

everythinglearnresearchcommunity

for

Search:↓

Anthralin cream helped 25% of patients with severe alopecia areata regrow hair, but caused skin irritation.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

PUVA treatment is generally ineffective for alopecia areata.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Triamcinolone acetonide injections help hair regrow quickly in mild alopecia but not in severe cases.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Topical Ruxolitinib may safely treat severe hair loss.

Alopecia areata treatment varies, with no optimal method established yet.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Most children treated with diphencyprone regrew some or all of their hair.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Animal models have helped understand hair loss from alopecia areata and find new treatments.